Home/Filings/4/0001181431-07-037561
4//SEC Filing

Synova Healthcare Group Inc 4

Accession 0001181431-07-037561

CIK 0001316826operating

Filed

Jun 3, 8:00 PM ET

Accepted

Jun 4, 7:02 PM ET

Size

10.9 KB

Accession

0001181431-07-037561

Insider Transaction Report

Form 4
Period: 2007-05-31
Votis George Thomas
Director10% Owner
Transactions
  • Other

    Common stock, $.001 par value per share

    2007-05-31$0.82/sh333,334$273,33412,696,089 total(indirect: By Galt Industries, Inc.)
Holdings
  • Allendale options

    Exercise: $8.04From: 2007-01-12Exp: 2009-06-02Common stock, $.001 par value per share (11,664 underlying)
    5,128
  • 6.5% Senior Convertible Promissory Notes

    Exercise: $1.00From: 2007-01-12Exp: 2012-01-12Common stock, $.001 par value per share (295,000 underlying)
    295,000
  • Common stock purchase warrants

    Exercise: $1.00From: 2007-01-12Exp: 2012-01-12Common stock, $.001 par value per share (324,500 underlying)
    324,500
Footnotes (4)
  • [F1]The 333,334 shares of common stock that are the subject of this transaction are being delivered to a third party pusuant to an indemnification agreement entered into by the reporting person. This number was inadvertently misreported as 333,333 in the reporting person's Form 4 dated January 12, 2007, as amended.
  • [F2]Represents shares of the common stock of Synova Healthcare Group, Inc. ("Synova") that were deemed to be beneficially owned by the reporting person and were held in escrow and were subject to forfeiture during the one-year period following the merger described in footnote (3) below to satisfy certain indemnification claims of Synova, as provided in an indemnification agreement entered into by the reporting person.
  • [F3]Received in connection with the merger of Allendale Pharmaceuticals, Inc. ("Allendale") with and into a wholly-owned subsidiary of Synova. As of the merger effective time, each share of Allendale common stock was converted into the right to receive approximately 2.275 shares of Synova common stock. Each option to purchase Allendale common stock was retained, except that such option became exercisable to purchase a number of shares of Synova common stock equal to the number of shares of Allendale common stock underlying such option, multiplied by the exchange ratio in the merger.
  • [F4]Reflects the number of shares of Allendale common stock that the option was originally entitled to receive prior to the merger.

Issuer

Synova Healthcare Group Inc

CIK 0001316826

Entity typeoperating

Related Parties

1
  • filerCIK 0001316826

Filing Metadata

Form type
4
Filed
Jun 3, 8:00 PM ET
Accepted
Jun 4, 7:02 PM ET
Size
10.9 KB